Clinical Trial Update: Allogenic Plasma Aliquots in the Treatment of Ligneous Conjunctivitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating allogeneic plasma aliquots for ligneous conjunctivitis is currently enrolling by invitation. The trial sponsor is Dorothy Bautista, M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ligneous Conjunctivitis

Drugs mentioned

• Allogeneic plasma aliquots (allogeneic plasma)

Snippet

Sponsor: Dorothy Bautista, MD | Conditions: Ligneous Conjunctivitis, Left Eye | Phase 3 | Status: ENROLLING_BY_INVITATION